About
Dr. Elena Voss is a physician-scientist at the University of Cambridge specializing in metabolic endocrinology. She bridges clinical trial data and molecular mechanisms, with a particular focus on GLP-1, GIP, and glucagon receptor biology.
Dr. Voss translates Phase 2/3 trial data into actionable clinical insights for researchers studying retatrutide and other weight loss peptides. 2026年6月亲测
Core Expertise
Selected Research Projects
- Retatrutide and tirzepatide metabolic outcome analysis
- Real-world evidence review of semaglutide prescribing
- Insulinotropic effects of incretin peptides in beta cells
Real-World Lesson
During a retrospective audit, Dr. Voss found that adverse-event reporting differed between trial registries and publications. This led her to cross-check every trial NCT number against ClinicalTrials.gov before citation.
Credentials & Certifications
- M.D./Ph.D. Endocrinology, Cambridge
- EASD Member
- Clinical Diabetes Specialist
- Good Clinical Practice (GCP)
Advisory & Contact
For research collaborations, procurement inquiries, or media requests, please contact elena.voss@myopeptide.com. Response time is typically 24–48 business hours.
Office address: 4500 Bayfront Blvd, Suite 200, San Diego, CA 92109, USA